Irritable bowel syndrome
Keywords: irritable bowel syndrome, IBX
AbstractIrritable bowel syndrome (IBS) is a condition that a significant number of people suffer from daily, yet it still remains misunderstood and thus difficult to treat or manage. It is a common condition that affects patients physically, psychologically, socially and economically.1 Also sometimes referred to as spastic colon, IBS is defined as a functional gastrointestinal (GI) disorder.1,2 It is usually characterised by stomach cramps, abdominal pain and intermittent diarrhoea occurring over a period of at least 3 months.3,4 It is important to note that IBS is not a disease, but rather a functional disorder, meaning an abnormal function of the bowels, that results in a number of symptoms. Other symptoms include, bloating, gassiness or flatulence, and bowel habits that alternate between periods of diarrhoea (IBS-D) and constipation (IBS-C).1,2
By submitting manuscripts to SAPA, authors of original articles are assigning copyright to the Publisher, Medpharm Publications (Pty) Ltd, unless otherwise specified. Authors may use their own work after publication without written permission, provided they acknowledge the original source. Individuals and academic institutions may freely copy and distribute articles published in SAPA for educational and research purposes without obtaining permission.